- Home
- Publications
- Publication Search
- Publication Details
Title
Host genomics and HCV treatment response
Authors
Keywords
-
Journal
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume 27, Issue 2, Pages 212-222
Publisher
Wiley
Online
2011-09-15
DOI
10.1111/j.1440-1746.2011.06918.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse
- (2011) Pablo Labarga et al. AIDS
- IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin
- (2011) Norma I Rallón et al. AIDS
- The Effects of IL-28B and ITPA Polymorphisms on Treatment of Hepatitis C Virus Genotype 6
- (2011) Wai-Kay Seto et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance
- (2011) Julia di Iulio et al. HEPATOLOGY
- Limited use of interleukin 28B in the setting of response-guided treatment with detailed on-treatment virological monitoring
- (2011) Alessandra Mangia et al. HEPATOLOGY
- IL28Bgenetic variation and treatment response in patients with hepatitis C virus genotype 3 infection
- (2011) Amir Moghaddam et al. HEPATOLOGY
- Genetic variation in the interleukin -28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection
- (2011) Francesco Marabita et al. HEPATOLOGY
- Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virus
- (2011) Nobuhiko Hiraga et al. HEPATOLOGY
- Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C
- (2011) Lucy Golden-Mason et al. HEPATOLOGY
- Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C
- (2011) Hans L. Tillmann et al. JOURNAL OF HEPATOLOGY
- Pre-treatment prediction of response to pegylated-interferon plus ribavarin for chronic hepatitis C using RVR
- (2011) H. Jafferbhoy et al. JOURNAL OF HEPATOLOGY
- IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C
- (2011) P.-Y. Bochud et al. JOURNAL OF HEPATOLOGY
- 12 IL28B POLYMORPHISM PREDICTS VIROLOGIC RESPONSE IN PATIENTS WITH HEPATITIS C GENOTYPE 1 TREATED WITH BOCEPREVIR (BOC) COMBINATION THERAPY
- (2011) F. Poordad et al. JOURNAL OF HEPATOLOGY
- 13 SIMILAR SVR RATES IN IL28B CC, CT OR TT PRIOR RELAPSER PARTIAL- OR NULL-RESPONDER PATIENTS TREATED WITH TELAPREVIR/PEGINTERFERON/RIBAVIRIN: RETROSPECTIVE ANALYSIS OF THE REALIZE STUDY
- (2011) S. Pol et al. JOURNAL OF HEPATOLOGY
- 1369 TELAPREVIR SUBSTANTIALLY IMPROVED SVR RATES ACROSS ALL IL28B GENOTYPES IN THE ADVANCE TRIAL
- (2011) I.M. Jacobson et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2011) JOURNAL OF HEPATOLOGY
- Viral genotype-specific role of PNPLA3 , PPARG , MTTP, and IL28B in hepatitis C virus-associated steatosis
- (2011) Tao Cai et al. JOURNAL OF HEPATOLOGY
- Genetic Variation in IL28B and Treatment-induced Clearance of Hepatitis C Virus in HIV-Positive Patients With Acute and Chronic Hepatitis C
- (2011) J. Nattermann et al. JOURNAL OF INFECTIOUS DISEASES
- IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C
- (2011) Kazuaki Chayama et al. JOURNAL OF INFECTIOUS DISEASES
- IL28Bpolymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1
- (2011) M. Lindh et al. JOURNAL OF VIRAL HEPATITIS
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL28B SNP rs12979860 Is a Critical Predictor for On-Treatment and Sustained Virologic Response in Patients with Hepatitis C Virus Genotype-1 Infection
- (2011) Chun-Yen Lin et al. PLoS One
- Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms
- (2011) Martin Lagging et al. PLoS One
- Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients
- (2010) Norma I Rallón et al. AIDS
- Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naïve Patients With Chronic Hepatitis C
- (2010) Albert Friedrich Stättermayer et al. Clinical Gastroenterology and Hepatology
- Modeling the Probability of Sustained Virological Response to Therapy with Pegylated Interferon plus Ribavirin in Patients Coinfected with Hepatitis C Virus and HIV
- (2010) Jose Medrano et al. CLINICAL INFECTIOUS DISEASES
- Prediction of Response to Pegylated Interferon plus Ribavirin byIL28BGene Variation in Patients Coinfected with HIV and Hepatitis C Virus
- (2010) Juan A. Pineda et al. CLINICAL INFECTIOUS DISEASES
- An IL28B Polymorphism Determines Treatment Response of Hepatitis C Virus Genotype 2 or 3 Patients Who Do Not Achieve a Rapid Virologic Response
- (2010) Alessandra Mangia et al. GASTROENTEROLOGY
- Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus
- (2010) Alexander J. Thompson et al. GASTROENTEROLOGY
- Variants in IL28B in Liver Recipients and Donors Correlate With Response to Peg-Interferon and Ribavirin Therapy for Recurrent Hepatitis C
- (2010) Takasuke Fukuhara et al. GASTROENTEROLOGY
- A Polymorphism Near IL28B Is Associated With Spontaneous Clearance of Acute Hepatitis C Virus and Jaundice
- (2010) Hans L. Tillmann et al. GASTROENTEROLOGY
- Replicated Association Between an IL28B Gene Variant and a Sustained Response to Pegylated Interferon and Ribavirin
- (2010) Jeanette J. McCarthy et al. GASTROENTEROLOGY
- Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C
- (2010) Masao Honda et al. GASTROENTEROLOGY
- Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
- (2010) Andri Rauch et al. GASTROENTEROLOGY
- Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response Than IL28B Genotype in Patients With Hepatitis C
- (2010) Michael T. Dill et al. GASTROENTEROLOGY
- HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy
- (2010) C. N. Hayes et al. GUT
- IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C
- (2010) Thomas J. Urban et al. HEPATOLOGY
- Potential role for Interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection
- (2010) Jason Grebely et al. HEPATOLOGY
- Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection
- (2010) Josephine H. Li et al. HEPATOLOGY
- Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection
- (2010) Andrew J. Muir et al. HEPATOLOGY
- Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection
- (2010) Michael R. Charlton et al. HEPATOLOGY
- Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients
- (2010) Ming-Lung Yu et al. HEPATOLOGY
- Pharmacodynamics of PEG-IFN-α-2a and HCV Response as a Function of IL28B Polymorphism in HIV/HCV-Coinfected Patients
- (2010) Evaldo Stanislau Affonso de Araújo et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection
- (2010) Christian M. Lange et al. JOURNAL OF HEPATOLOGY
- Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients
- (2010) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors
- (2010) Masayuki Kurosaki et al. JOURNAL OF HEPATOLOGY
- IL28BPolymorphism Does Not Determine Outcomes of Hepatitis B Virus or HIV Infection
- (2010) Maureen P. Martin et al. JOURNAL OF INFECTIOUS DISEASES
- Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation
- (2010) Dennis Eurich et al. LIVER TRANSPLANTATION
- Telaprevir for Previously Treated Chronic HCV Infection
- (2010) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL28B SNP rs8099917 Is Strongly Associated with Pegylated Interferon-α and Ribavirin Therapy Treatment Failure in HCV/HIV-1 Coinfected Patients
- (2010) Ester Aparicio et al. PLoS One
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
- (2009) David L. Thomas et al. NATURE
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Common Genetic Variation and Human Traits
- (2009) David B. Goldstein NEW ENGLAND JOURNAL OF MEDICINE
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- How to Interpret a Genome-wide Association Study
- (2008) Thomas A. Pearson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interleukin-29 Functions Cooperatively with Interferon to Induce Antiviral Gene Expression and Inhibit Hepatitis C Virus Replication
- (2008) Nicole E. Pagliaccetti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started